When synergized with other factors, IL-21 exerts a pivotal role in TSCM cell attainment and expansion, exemplified by the synergy with lactate dehydrogenase (LDH) inhibitor in a mouse model of pmel-1 specific TCR-T cell adoptive cancer immunotherapy [127]. This evidence concerns the gene IL21 and cancer.